| Identification | Back Directory | [Name]
1H-Cyclopenta[b]benzofuran-5-butanoic acid, 2,3,3a,8b-tetrahydro-2-hydroxy-1-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]-, sodium salt (1:1), (1R,2R,3aS,8bS)- | [CAS]
1290611-29-8 | [Synonyms]
GP1681
GP-1681
GP 1681
1H-Cyclopenta[b]benzofuran-5-butanoic acid, 2,3,3a,8b-tetrahydro-2-hydroxy-1-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]-, sodium salt (1:1), (1R,2R,3aS,8bS)- | [Molecular Formula]
C24H31NaO5 | [MOL File]
1290611-29-8.mol | [Molecular Weight]
422.5 |
| Hazard Information | Back Directory | [Description]
GP-1681 is a G-protein coupled receptor (GPCR) agonist potentially for the treatment of influenza infection. | [Definition]
ChEBI: Beraprost sodium is the organic sodium salt of beraprost. It is used in the treatment of chronic arterial occlusive disease and primary pulmonary hypertension in Japan. It has a role as an antihypertensive agent, a platelet aggregation inhibitor, a prostaglandin receptor agonist, a vasodilator agent and an anti-inflammatory agent. It contains a beraprost(1-). |
|
|